About the manufacturing of Dr. Lupo products
Therapeutic Peptides, Inc. and Biosyn, Inc. work closely to develop compounds and delivery agents for next generation of so-called cosmeceutical products.The new Biosyn R & D facilities include the latest spectra-fluorescence equipment for monitoring human fibroblast, keratinocyte and melanocyte cell culture responses to potential bio-active skin care ingredients. Biosyn possesses one of the largest human cell culture research programs dedicated to the development and understanding of topical bio-actives.
CTFA/FDA recommended procedures are followed for all microbilogical analysis. This includes tests for aspergillus niger, candida albicans, enterococcus faecalis, E. Coli, pseudomonas aeruginosa, staphylococcus epidermidis, anerobics, etc. Challenge testing is routinely done for all formulations to insure sufficient biocide levels for retail sales. In addition to standard plate culture techniques, multi-well testing for anti-microbial efficacy studies is performed on a Bio-Tek Instruments EL311 Autoreader. The QA/QC lab is responsible for conducting all long term product physical and microbiological stability testing OTC products requiring special FDA procedures.
